secwatch / observer
8-K filed September 2, 2026, 4:08 PM ET ticker SCTX CIK 0001853921
earnings confidence high sentiment positive materiality 0.75

Scribe Therapeutics Q2 2026 net loss $6.5M; cash $43M plus $140.6M IPO proceeds fund to H1 2029

Scribe Therapeutics, Inc.

Scribe Therapeutics, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-26-380184
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.